Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are bec...Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are becoming increasingly apparent1.To address these issues,a novel treatment strategy,the artificially intelligent synergistic engineered drug(AISED)paradigm,merits further exploration.This paradigm is based on the systematic engineered integration of multiple active ingredients into a unified single entity through artificial intelligence(AI).This strategy is aimed at developing new anti-cancer drug designs involving multiple ingredients,multiple molecular targets,and multiple biological effects,for multiple cancer types,thereby providing a novel theoretical paradigm for overcoming existing treatment bottlenecks.展开更多
The year 2025 marked the inaugural volume of Artificial Intelligence Science and Engineering(AISE).Withthe strong support of the global academic community in artificial intelligence and control science,and through the...The year 2025 marked the inaugural volume of Artificial Intelligence Science and Engineering(AISE).Withthe strong support of the global academic community in artificial intelligence and control science,and through thededicated efforts of our editorial board members,authors,and reviewers,all four issues were successfullypublished.These issues brought together significant original contributions and authoritative surveys from leadingscholars,laying a solid academic foundation for the long-term development of the journal.展开更多
文摘Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are becoming increasingly apparent1.To address these issues,a novel treatment strategy,the artificially intelligent synergistic engineered drug(AISED)paradigm,merits further exploration.This paradigm is based on the systematic engineered integration of multiple active ingredients into a unified single entity through artificial intelligence(AI).This strategy is aimed at developing new anti-cancer drug designs involving multiple ingredients,multiple molecular targets,and multiple biological effects,for multiple cancer types,thereby providing a novel theoretical paradigm for overcoming existing treatment bottlenecks.
文摘The year 2025 marked the inaugural volume of Artificial Intelligence Science and Engineering(AISE).Withthe strong support of the global academic community in artificial intelligence and control science,and through thededicated efforts of our editorial board members,authors,and reviewers,all four issues were successfullypublished.These issues brought together significant original contributions and authoritative surveys from leadingscholars,laying a solid academic foundation for the long-term development of the journal.
